Home> Products> innovative product

{ "products": [ { "_id": "6842b8014256f7114dfbd884", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "Trelagliptin 100mg in TRELAQWK 100 is an innovative once-weekly oral medication formulated with Trelagliptin 100mg, specifically designed to support adults in managing type 2 diabetes mellitus (T2DM). As a member of the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class, it provides a simplified and effective approach to improving glycemic control when combined with a healthy diet and regular exercise. Its weekly dosing schedule enhances treatment adherence, offering a more sustainable option for long-term diabetes care.\n\nActive Ingredient:\nTrelagliptin 100mg\nA potent, long-acting DPP-4 inhibitor that helps maintain stable blood glucose levels by preserving incretin activity. Incretins are natural hormones that promote insulin release and suppress glucagon, playing a vital role in blood sugar regulation.\n\nCore Benefits:\nConvenient once-weekly dosing enhances patient compliance\n\nEffectively lowers both fasting and postprandial (after-meal) blood sugar\n\nPromotes natural insulin production without contributing to weight gain\n\nCarries a low risk of hypoglycemia, especially when not used with insulin\n\nCan be used alone or in combination with other antidiabetic medications like metformin or sulfonylureas\n\nMechanism of Action:\nTRELAQWK 100 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These hormones play a crucial role in regulating blood sugar after meals. By prolonging their activity, Trelagliptin enhances insulin secretion and reduces glucagon levels, resulting in improved glycemic control. Its extended half-life allows for once-a-week administration, setting it apart from daily DPP-4 inhibitors.\n\nDosage & Administration:\nRecommended Dose: One tablet per week, or as advised by your doctor\n\nHow to Take: With or without food, preferably on the same day each week\n\nIf a dose is missed, do not double the next dose; seek guidance from your healthcare provider\n\nPossible Side Effects:\nTRELAQWK 100 is generally safe and well-tolerated. Some individuals may experience:\n\nHeadache\n\nNasopharyngitis (mild cold symptoms)\n\nConstipation\n\nUpper respiratory tract infections\n\nRare allergic reactions such as rashes or skin irritation\n\nSeek immediate medical advice if you experience unusual symptoms such as severe abdominal pain, persistent skin reactions, or signs of pancreatitis.", "price": 3.0, "discountamount": 1.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medical advice", "generally safe", "healthcare provider", "food preferably", "extended halflife", "crucial role", "dpp4 enzyme", "sulfonylureas mechanism", "antidiabetic medications", "low risk", "vital role", "sustainable option", "regular exercise", "healthy diet", "effective approach", "support adults", "trelaqwk 100trelaqwk 100", "hormones play", "natural hormones", "dose seek guidance", "promote insulin release", "degrades incretin hormones", "experience unusual symptoms", "skin irritation seek", "onceaweek administration setting", "improved glycemic control", "regulating blood sugar", "weight gain carries", "suppress glucagon playing", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2132, "imageuri": "https://productimages.withfloats.com/actual/6842b80c8a53ae8db15a02ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/6842b80c8a53ae8db15a02ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-06T09:42:25.371Z", "updatedon": "2025-06-11T11:17:09.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2132", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trelagliptin 100mg", "category": "DIABETIC RANGE", "tags": [ "Trelagliptin side effects", "Trelagliptin brand name", "Trelagliptin brands in India", "Trelagliptin uses", "Trelagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604960a743fd235821fba0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IMEGLIMON 500 ", "description": "IMEGLIMON 500 \nImeglimin Hydrochloride 500 mg\nIntroduction to IMEGLIMON 500\nIMEGLIMON 500 contains Imeglimin Hydrochloride 500mg, a novel oral medication used for the management of type 2 diabetes mellitus. Imeglimin represents a new class of oral antidiabetic agents known as \"glimins,\" which target multiple pathways involved in glucose metabolism. This medication helps improve blood sugar control by enhancing insulin sensitivity, increasing insulin secretion, and improving mitochondrial function.\n\nWhat is Imeglimin?\nOverview of Imeglimin\nImeglimin is an innovative oral antidiabetic agent that works through a multifaceted mechanism to improve glycemic control in patients with type 2 diabetes. Unlike traditional antidiabetic medications, Imeglimin targets multiple defects associated with type 2 diabetes, providing a comprehensive approach to managing blood sugar levels.\n\nMechanism of Action\nInsulin Sensitization: Imeglimin enhances insulin sensitivity in muscle and liver tissues, leading to improved glucose uptake and utilization.\nInsulin Secretion: It increases insulin secretion in response to glucose, helping to maintain more stable blood sugar levels.\nMitochondrial Function: Imeglimin improves mitochondrial function, which helps to reduce oxidative stress and improve overall cellular energy metabolism.\nBenefits of IMEGLIMON 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: IMEGLIMON 500 helps regulate both postprandial (after-meal) and fasting blood glucose levels by improving insulin sensitivity and secretion.\nComprehensive Glycemic Control: The unique mechanism of action of Imeglimin addresses multiple pathways involved in glucose metabolism, providing comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: IMEGLIMON 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, IMEGLIMON 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nImproved Mitochondrial Function: The positive effects on mitochondrial function can lead to reduced oxidative stress and improved overall cellular health.\nWeight Management: Imeglimin has a neutral effect on body weight, making it a suitable option for patients concerned about weight gain associated with some antidiabetic medications.\nHow to Use IMEGLIMON 500\nDosage and Administration\nRecommended Dosage: The typical dosage of IMEGLIMON 500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to enhance absorption and reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take IMEGLIMON 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/imeglimon-500-134379", "price": 159.0, "discountamount": 47.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "Diet", "EMAIL", "Order", "water", "meals", "Action", "muscle", "option", "glimins", "Support", "patients", "readings", "Overview", "new class", "IMEGLIMON", "one tablet", "absorption", "Guidelines", "full glass", "neuropathy", "Optimal Use", "utilization", "body weight", "weight gain", "retinopathy", "Adjustments", "information", "Postprandial", "Reduced Risk", "sterispharma", "Introduction", "best results", "sterisonline", "CALL/WHATSAPP", "liver tissues", "Administration", "glucose uptake", "Consistent Use", "neutral effect", "treatment plan", "typical dosage", "positive effects", "multiple defects", "unique mechanism", "Exercise Adjunct", "oxidative stress", "Weight Management", "multiple pathways", "excellent adjunct", "insulin secretion", "glucose metabolism", "Recommended Dosage", "Diabetes Management", "blood sugar control", "insulin sensitivity", "individual response", "healthcare provider", "blood glucose levels", "Insulin Sensitization", "novel oral medication", "multifaceted mechanism", "cardiovascular disease", "comprehensive approach", "mitochondrial function", "overall cellular health", "Fasting Glucose Control", "lifestyle modifications", "Imeglimin Hydrochloride", "long-term complications", "type 2 diabetes mellitus", "oral antidiabetic agents", "stable blood sugar levels", "Additional Health Benefits", "gastrointestinal discomfort", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "overall cellular energy metabolism", "innovative oral antidiabetic agent", "traditional antidiabetic medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1375, "imageuri": "https://productimages.withfloats.com/actual/66604962487c46164ce29d69.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604962487c46164ce29d69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:17:52.343Z", "updatedon": "2024-06-29T12:01:46.362Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imeglimon-500-/1375", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMEGLIMON 500 ", "category": "DIABETIC RANGE", "tags": [ "IMEGLIMON 500", "Imeglimin Hydrochloride 500 mg", "Imeglimin hydrochloride 500 mg uses", "Imeglimin 500 Uses in Hindi", "Imeglimin 500 price", "Imeglimin hydrochloride tablets 1000mg", "Imeglimin side effects", "Imeglimin dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665efaa48ecffe165c350b61", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA TENE 10/20 ", "description": "GLIDAPA TENE 10/20 \nDapagliflozin & Teneligliptin\nIntroduction\nGLIDAPA TENE 10/20 is a cutting-edge oral medication engineered for the management of Type 2 diabetes. This combination therapy includes Dapagliflozin (10 mg) and Teneligliptin (20 mg), two powerful drugs that work synergistically to control high blood sugar levels effectively.\n\nHow It Works\n\nDapagliflozin (10 mg): Dapagliflozin belongs to the class of drugs known as SGLT2 inhibitors. It works by preventing the kidneys from reabsorbing glucose back into the blood, promoting the excretion of glucose through urine. This leads to a reduction in blood glucose levels and can also aid in weight loss and blood pressure control.\nTeneligliptin (20 mg): Teneligliptin is a DPP-4 inhibitor that enhances the body's natural ability to lower blood sugar levels by increasing the release of insulin and decreasing the release of glucagon after meals. This helps to smooth out blood sugar spikes that can occur post-meal.\nBenefits\nGLIDAPA TENE 10/20 offers a comprehensive approach to diabetes management by targeting different pathways in glucose metabolism. The combination of Dapagliflozin and Teneligliptin provides a dual mechanism of action, which can be more effective in lowering blood glucose levels compared to monotherapy. This can also lead to improvements in HbA1c levels, a key indicator of long-term glycemic control.\n\nDosage and Administration\n\nDosage: The standard dosage is one tablet per day, but it should be adjusted based on the patient's specific medical condition, tolerance, and the effectiveness of the treatment.\nAdministration: GLIDAPA TENE 10/20 should be taken in the morning with or without food. Consistent daily intake helps maintain stable drug levels in the blood and ensures maximum efficacy.\nSide Effects\nThe most common side effects associated with GLIDAPA TENE 10/20 may include urinary tract infections due to the increased glucose in urine, and gastrointestinal disturbances such as nausea or constipation. Patients may also experience a slight risk of dehydration and should be advised to maintain adequate fluid intake.\n\nConclusion\nGLIDAPA TENE 10/20 is an innovative medication for managing Type 2 diabetes, providing potent dual-action control over high blood sugar levels. It simplifies the treatment regimen by combining two effective medications into a single daily dose, potentially enhancing patient compliance and improving overall diabetes management. As always, patients should consult their healthcare provider for personalized advice and to adjust the treatment plan as needed to achieve optimal health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-tene-10-20-134223", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "meals", "urine", "Order", "class", "EMAIL", "nausea", "insulin", "morning", "release", "kidneys", "Patients", "glucagon", "Benefits", "excretion", "reduction", "tolerance", "Conclusion", "one tablet", "slight risk", "dehydration", "weight loss", "information", "monotherapy", "Introduction", "GLIDAPA TENE", "sterisonline", "HbA1c levels", "improvements", "constipation", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "key indicator", "dual mechanism", "treatment plan", "standard dosage", "Type 2 diabetes", "DPP-4 inhibitor", "natural ability", "maximum efficacy", "SGLT2 inhibitors", "single daily dose", "treatment regimen", "different pathways", "two powerful drugs", "glucose metabolism", "stable drug levels", "blood sugar spikes", "patient compliance", "personalized advice", "common side effects", "healthcare provider", "combination therapy", "blood glucose levels", "Teneligliptin (20 mg", "innovative medication", "Administration Dosage", "adequate fluid intake", "comprehensive approach", "blood pressure control", "optimal health outcomes", "high blood sugar levels", "Consistent daily intake", "urinary tract infections", "two effective medications", "specific medical condition", "long-term glycemic control", "potent dual-action control", "overall diabetes management", "gastrointestinal disturbances", "cutting-edge oral medication engineered" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1296, "imageuri": "https://productimages.withfloats.com/actual/665efaa8d93d0ca61a4976f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efaa8d93d0ca61a4976f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:29:40.684Z", "updatedon": "2024-06-04T11:29:40.684Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-tene-10-20-/1296", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENE 10/20 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ee8be7b387b17ecbcbde3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " SACUBRIGHT 200 ", "description": "SACUBRIGHT 200 \nSacubitril (97mg), Valsartan (103mg)\nSACUBRIGHT 200 is a combination medication containing two active ingredients: Sacubitril (97mg) and Valsartan (103mg). This combination is designed to provide dual inhibition of the renin-angiotensin-aldosterone system (RAAS) for the treatment of heart failure with reduced ejection fraction (HFrEF).\n\nSacubitril is a neprilysin inhibitor, while Valsartan is an angiotensin II receptor blocker (ARB). Together, they work synergistically to improve cardiovascular outcomes in patients with HFrEF by targeting different pathways involved in the pathophysiology of heart failure.\n\nNeprilysin is an enzyme responsible for the degradation of natriuretic peptides, which play a crucial role in regulating blood pressure and fluid balance. By inhibiting neprilysin, Sacubitril increases the levels of natriuretic peptides, leading to vasodilation, natriuresis, and diuresis, which helps reduce blood pressure, preload, and afterload on the heart.\n\nValsartan, as an ARB, blocks the effects of angiotensin II, a vasoconstrictor and stimulator of aldosterone secretion. By antagonizing the angiotensin II type 1 (AT1) receptors, Valsartan dilates blood vessels, reduces blood pressure, and attenuates the deleterious effects of angiotensin II on cardiac remodeling and fibrosis.\n\nSACUBRIGHT 200 is indicated for the treatment of symptomatic HFrEF in patients with New York Heart Association (NYHA) class II-IV heart failure. Clinical studies have demonstrated that this combination therapy reduces the risk of cardiovascular death and hospitalization for heart failure compared to traditional therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) alone.\n\nAs with any medication, SACUBRIGHT 200 may cause side effects, including hypotension, hyperkalemia, renal impairment, and angioedema. Patients should be monitored regularly for these adverse effects, especially during initiation and dose titration.\n\nOverall, SACUBRIGHT 200 represents an innovative approach to the management of HFrEF, offering superior efficacy and cardiovascular benefits compared to standard therapy. However, it should only be used under the supervision of a healthcare professional experienced in the management of heart failure and in accordance with established treatment guidelines.\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/sacubright-200-134307\n\n\n\n", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARB", "risk", "RAAS", "EMAIL", "Order", "levels", "diuresis", "fibrosis", "patients", "Valsartan", "stimulator", "initiation", "angioedema", "SACUBRIGHT", "accordance", "management", "Sacubitril", "natriuresis", "degradation", "information", "supervision", "hypotension", "sterisonline", "sterispharma", "hyperkalemia", "vasodilation", "side effects", "crucial role", "CALL/WHATSAPP", "fluid balance", "blood vessels", "dose titration", "AT1) receptors", "blood pressure", "dual inhibition", "adverse effects", "pathophysiology", "hospitalization", "vasoconstrictor", "standard therapy", "renal impairment", "Clinical studies", "symptomatic HFrEF", "superior efficacy", "different pathways", "cardiac remodeling", "combination therapy", "deleterious effects", "innovative approach", "traditional therapy", "treatment guidelines", "neprilysin inhibitor", "cardiovascular death", "natriuretic peptides", "angiotensin II type 1", "aldosterone secretion", "two active ingredients", "combination medication", "cardiovascular outcomes", "cardiovascular benefits", "healthcare professional", "reduced ejection fraction", "New York Heart Association", "angiotensin receptor blockers", "angiotensin II receptor blocker", "NYHA) class II-IV heart failure", "renin-angiotensin-aldosterone system", "angiotensin-converting enzyme (ACE) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1279, "imageuri": "https://productimages.withfloats.com/actual/665ee8c06030c166b1a41ef3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ee8c06030c166b1a41ef3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:13:18.717Z", "updatedon": "2024-06-04T10:13:18.717Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-sacubright-200-/1279", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril (97mg), Valsartan (103mg)", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b9b3ce0b5041cf8896b70", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ABIRASTERON 250 ", "description": "ABIRASTERON 250 \nAbiraterone Acetate lp (250mg) \nABIRASTERON 250, containing Abiraterone Acetate lp at 250mg strength, is a vital medication used in the treatment of advanced prostate cancer. This innovative formulation targets and inhibits the production of androgens, hormones that fuel prostate cancer growth. By blocking androgen production, ABIRASTERON 250 effectively slows down cancer progression, improves symptoms, and enhances overall quality of life for patients. It is usually prescribed in combination with other therapies and under close medical supervision to achieve optimal outcomes in managing advanced prostate cancer.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 39000.0, "discountamount": 11700.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "symptoms", "hormones", "patients", "androgens", "treatment", "combination", "ABIRASTERON", "250mg strength", "other therapies", "overall quality", "optimal outcomes", "vital medication", "cancer progression", "androgen production", "innovative formulation", "Abiraterone Acetate lp", "prostate cancer growth", "advanced prostate cancer", "close medical supervision" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 767, "imageuri": "https://productimages.withfloats.com/actual/662b9b3f0f245019b82ae0df.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b9b3f0f245019b82ae0df.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:17:00.614Z", "updatedon": "2024-06-07T12:32:10.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//abirasteron-250-/767", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Abiraterone Acetate lp (250mg)", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb194933ec7924333073c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PYRITIGMIN RIVA 1.5", "description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.", "price": 192.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2176, "imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:36:04.37Z", "updatedon": "2025-09-08T10:36:04.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rivastigmine 1.5 mg capsule", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68a59c17b327016e049d0a83", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RIFAXEMANIA 400", "description": "RIFAXEMANIA 400 contains Rifaximin 400 mg, a special type of antibiotic that works mainly in the intestines. Unlike many other antibiotics that get absorbed into the bloodstream, rifaximin stays in the digestive tract, making it highly effective for infections and conditions related to the gut while minimizing unwanted effects on the rest of the body.\n\nIt belongs to the rifamycin class of antibiotics and is particularly useful for reducing harmful bacteria in the intestines, restoring gut balance, and improving digestive health. Doctors commonly prescribe it for traveler’s diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy.\n\nUses of RIFAXEMANIA 400\n\nRIFAXEMANIA 400 is recommended for:\n\nTraveler’s Diarrhea: Effective against non-invasive strains of Escherichia coli.\n\nHepatic Encephalopathy: Helps reduce the recurrence of confusion and related symptoms by lowering the production of toxins such as ammonia in the gut.\n\nIrritable Bowel Syndrome with Diarrhea (IBS-D): Provides relief from abdominal pain, bloating, and frequent loose stools.\n\nSmall Intestinal Bacterial Overgrowth (SIBO): Often prescribed off-label for managing bacterial imbalance in the small intestine.\n\nPrevention of gut-related complications in chronic liver disease.\n\nSide Effects of RIFAXEMANIA 400\n\nMost people tolerate RIFAXEMANIA 400 well because of its local action in the intestines. However, like any medication, some side effects may occur, such as:\n\nNausea or vomiting\n\nHeadache or dizziness\n\nAbdominal pain, bloating, or gas\n\nConstipation or diarrhea (rare)\n\nTiredness or weakness\n\nRash, itching, or other mild allergic reactions\n\nSerious side effects are rare but may include severe diarrhea, persistent abdominal cramps, or signs of allergy such as swelling and breathing difficulty. If these occur, medical help should be sought immediately.\n\nPrecautions Before Using RIFAXEMANIA 400\n\nPatients should keep in mind the following precautions:\n\nDo not use if you are allergic to rifaximin, rifampin, or other rifamycin antibiotics.\n\nAvoid self-medication if you have fever, bloody stools, or severe abdominal pain, as these may indicate a more serious illness.\n\nPatients with advanced liver problems should take the medicine under close medical supervision.\n\nSafety during pregnancy and breastfeeding has not been fully established—consult a doctor before use.\n\nComplete the prescribed course, even if symptoms improve early, to avoid recurrence.\n\nNot meant for viral infections like flu or the common cold.\n\nDrug Interactions\n\nThough rifaximin is minimally absorbed, some drug interactions may occur:\n\nWarfarin or other anticoagulants: May require monitoring of blood clotting.\n\nOther antibiotics: Combining with multiple antibiotics may reduce effectiveness.\n\nCyclosporine and similar drugs: May increase rifaximin levels in the body.\n\nOral contraceptives: Effectiveness may be lowered; consider additional contraception.\n\nAlways share your full list of medications, supplements, or herbal products with your doctor before starting RIFAXEMANIA 400.\n\nConclusion\n\nRIFAXEMANIA 400 (Rifaximin 400 mg) is a trusted and effective choice for managing gastrointestinal conditions like traveler’s diarrhea, IBS-D, hepatic encephalopathy, and bacterial overgrowth syndromes. Its unique property of acting directly in the intestines ensures high effectiveness with fewer systemic side effects.\n\nFor best results, patients should use RIFAXEMANIA 400 only under medical guidance, follow the recommended dosage, and complete the prescribed course.", "price": 516.0, "discountamount": 155.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2164, "imageuri": "https://productimages.withfloats.com/actual/68a59c1f9d5616eb474a3a41.png", "tileimageuri": "https://productimages.withfloats.com/tile/68a59c1f9d5616eb474a3a41.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-20T09:57:43.02Z", "updatedon": "2025-08-20T09:57:43.02Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rifaxemania-400/2164", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rifaximin 400", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }